Melissa Price

Melissa Price, PhD, serves as the Senior Vice President of Development Program Leadership at Bicycle Therapeutics since January 2024. Previously held the position of Senior Vice President, Head of Development Operations and Portfolio Strategy at 2seventy bio, where significant contributions included driving the early-stage pipeline of CAR and TCR products that resulted in multiple products entering clinical trials. Prior roles include Senior Vice President of Oncology Emerging Products at bluebird bio, Vice President of Program and Alliance Management at Kaleido Biosciences, and Vice President of Clinical Development at TARIS Biomedical, among others, with a focus on oncology and clinical developments. Melissa Price holds a PhD in Organic Chemistry from Yale University and has completed management courses at MIT Sloan School of Management and Cambridge University.